Letermovir Prophylaxis Guided by Cytomegalovirus Cell-Mediated Immunity Improves the Outcomes of Allogeneic Hematopoietic Stem Cell Transplant Recipients
CMV-CMI-guided letermovir prophylaxis may help reduce the risk of late-onset cs-CMVi, particularly in individuals at high risk.
Authors
- Luxiang Wang (ORCID: https://orcid.org/0000-0002-8320-8784)
- Haiyang Lu
- Xiaoxia Hu (ORCID: https://orcid.org/0000-0002-2719-3805)
- Quan Chen (ORCID: https://orcid.org/0000-0001-7539-8728)
- Jiayu Huang (ORCID: https://orcid.org/0000-0001-5195-1330)
- Zengkai Pan
- Meijuan Huang
- Jun Zhu (ORCID: https://orcid.org/0000-0003-1824-7610)
- Zilu Zhang (ORCID: https://orcid.org/0009-0000-2180-5957)
- Yang Cao (ORCID: https://orcid.org/0000-0003-0152-639X)
- Li Su (ORCID: https://orcid.org/0000-0003-1791-7731)
- Jingtao Huang (ORCID: https://orcid.org/0009-0005-4462-758X)
- Yang He (ORCID: https://orcid.org/0000-0001-7010-6319)
- Xiaojia Guo
- Chuanhe Jiang
Institutions
- Second Military Medical University (CN)
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Naval Health Research Center (US)
- Lanzhou University Second Hospital (CN)
- Punan Hospital (CN)
- Shanghai Institute of Hematology (CN)
- People's Liberation Army 411 Hospital (CN)
- Shanghai Skin Disease Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1093/cid/ciaf410
- Citations
- 6
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 8.13